Endocrinology, Vol 117, 2114-2119, Copyright © 1985 by Endocrine Society

ARTICLES

1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture

LK Cantley, J Russell, D Lettieri and LM Sherwood

To determine whether 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] regulates PTH secretion, we have tested its effects in both short term incubations (30-120 min) and long term primary cell cultures (24-96 h) of bovine parathyroid cells. In short term incubations, 10(-11)-10(-7) M 1,25-(OH)2D3 had no consistent effect on PTH secretion. In primary cultures of bovine parathyroid cells, significant suppression of PTH secretion occurred, as measured by both N-terminal and C-terminal PTH assays. Suppression of PTH secretion was dose dependent when 10(-11), 10(-9), and 10(-7) M 1,25-(OH)2D3 were tested for 48 h in culture, and the effects of 10(-7) M, 1,25-(OH)2D3 were noted as early as 24 h. Reversal of suppression of PTH secretion was observed after an additional 48 h in the absence of 1,25-(OH)2D3. Other studies from our laboratory have demonstrated that 1,25-(OH)2D3 suppresses levels of pre- pro-PTH mRNA in cultured bovine parathyroid cells, and we found a strong correlation at 48 h between the decrease in PTH release and that in mRNA. We conclude that 1) 1,25-(OH)2D3 suppresses PTH secretion rates in a dose-dependent manner in cells grown for 24-48 h in culture, but does not have a significant effect on short term PTH release (30- 120 min); 2) cultured cells exhibiting suppression by 1,25-(OH)2D3 demonstrate nearly full recovery of PTH secretion after an additional 48 h in the absence of added 1,25-(OH)2D3; and 3) PTH secretion closely parallels levels of pre-pro-PTH mRNA in cultured cells, suggesting that the observed effects of PTH secretion reflect, at least in part, suppression of synthesis of PTH by 1,25-(OH)2D3.

This article has been cited by other articles:

				E. H. Samander and A. Arnold Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5019 - 5021. [Abstract] [Full Text] [PDF]

				Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Exogenous 1,25-Dihydroxyvitamin D3 Exerts a Skeletal Anabolic Effect and Improves Mineral Ion Homeostasis in Mice that Are Homozygous for Both the 1{alpha}-Hydroxylase and Parathyroid Hormone Null Alleles Endocrinology, October 1, 2006; 147(10): 4801 - 4810. [Abstract] [Full Text] [PDF]

				Y. Xue, A. C. Karaplis, G. N. Hendy, D. Goltzman, and D. Miao Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development Hum. Mol. Genet., June 1, 2005; 14(11): 1515 - 1528. [Abstract] [Full Text] [PDF]

				S. Komuro, M. Sato, and H. Kanamaru DISPOSITION AND METABOLISM OF F6-1{alpha},25(OH)2 VITAMIN D3 AND 1{alpha},25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDS Drug Metab. Dispos., August 1, 2003; 31(8): 973 - 978. [Abstract] [Full Text] [PDF]

				U. Segersten, P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling, G. Akerstrom, and G. Westin 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Expression in Normal and Pathological Parathyroid Glands J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2967 - 2972. [Abstract] [Full Text] [PDF]

				A. J. Brown, A. Dusso, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175. [Abstract] [Full Text] [PDF]

				J. L. FINCH, A. J. BROWN, and E. SLATOPOLSKY Differential Effects of 1,25-Dihydroxy-Vitamin D3 and 19-Nor-1,25-Dihydroxy-Vitamin D2 on Calcium and Phosphorus Resorption in Bone J. Am. Soc. Nephrol., May 1, 1999; 10(5): 980 - 985. [Abstract] [Full Text]

				N. Koike, N. Hayakawa, K. Kumaki, and W. E. Stumpf In Vivo Dose-related Receptor Binding of the Vitamin D Analogue [3H]-1,25-dihydroxy-22-oxavitamin D3 (OCT) in Rat Parathyroid, Kidney Distal and Proximal Tubules, Duodenum, and Skin, Studied by Quantitative Receptor Autoradiography J. Histochem. Cytochem., December 1, 1998; 46(12): 1351 - 1358. [Abstract] [Full Text]

				Y. C. Li, M. Amling, A. E. Pirro, M. Priemel, J. Meuse, R. Baron, G. Delling, and M. B. Demay Normalization of Mineral Ion Homeostasis by Dietary Means Prevents Hyperparathyroidism, Rickets, and Osteomalacia, But Not Alopecia in Vitamin D Receptor-Ablated Mice Endocrinology, October 1, 1998; 139(10): 4391 - 4396. [Abstract] [Full Text] [PDF]

				E. Soliman, L. Canaff, J. Fox, and G. N. Hendy In Vivo Regulation of Chromogranin A Messenger Ribonucleic Acid in the Parathyroid by 1,25-Dihydroxyvitamin D: Studies in Normal Rats and in Chronic Renal Insufficiency Endocrinology, June 1, 1997; 138(6): 2596 - 2600. [Abstract] [Full Text] [PDF]

				N. A T Hamdy, J. A Kanis, M. N C Beneton, C. B Brown, J. R Juttmann, J. G M Jordans, S. Josse, A. Meyrier, R. L Lins, and I. T Fairey Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure BMJ, February 11, 1995; 310(6976): 358 - 363. [Abstract] [Full Text]